← All trials
NCT05322590
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2022
- Primary completion
- Apr 30, 2026
- Completion date
- Apr 30, 2029
- First posted
- Apr 12, 2022
- Last posted
- Oct 31, 2022
- Enrollment
- 195
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Bexion Pharmaceuticals, LLC.Lead sponsor
- Bexion Pharmaceuticals, LLC.Study director
- ICONCollaborator
- CTI Clinical Trial and Consulting ServicesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.